Health ❯ Healthcare ❯ Clinical Trials ❯ Phase 3 Trials

CheckMate-067

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma

NYU Langone Health researchers link the HG-T variant to weakened T cell responses with plans to test haplogroup-guided immunotherapy.